Active individuals who want to lose stubborn fat, keep or build muscle, and improve energy often look for options beyond diet and training alone. This popular compounded injectable blend combines AOD-9604 (1.2 mg/mL), MOTS-c (2 mg/mL), and Tesamorelin (3 mg/mL) in a 5 mL vial. It targets three complementary aspects of fat metabolism: direct fat breakdown, cellular energy and metabolic regulation, and reduction of deep visceral (belly) fat. Many users combine it with a GLP-1 medication (semaglutide, tirzepatide, or retatrutide) for even stronger appetite control and results. No large clinical trials have tested this exact blend, but the individual peptides have supporting primary studies.
What Are These Compounds?
- AOD-9604 (1.2 mg/mL): A short 16-amino-acid fragment of human growth hormone designed to promote fat breakdown (lipolysis) without the full effects of growth hormone.
- MOTS-c (2 mg/mL): A mitochondrial-derived peptide that rises naturally during exercise. It acts as an “exercise mimetic,” improving energy use, fat burning, and insulin sensitivity.
- Tesamorelin (3 mg/mL): A growth hormone-releasing hormone (GHRH) analog that stimulates natural GH pulses, especially effective at reducing deep abdominal (visceral) fat.
The blend is typically injected daily or several times per week, with dosing adjusted by the prescribing clinic.
AOD-9604: Direct Fat Mobilization
AOD-9604 stimulates lipolysis in fat cells. Human trials (over 900 participants) showed it was safe with no major rise in IGF-1 or blood sugar changes. Early studies reported modest extra weight loss (around 2–3 kg more than placebo in some 12-week trials), and it is often used to help release stubborn fat during a calorie deficit.
MOTS-c: Metabolic Efficiency and Endurance Support
MOTS-c activates AMPK, the cell’s energy sensor, to boost fat oxidation, glucose uptake, and new mitochondria formation. In animal studies, it improved running capacity, protected against obesity, and enhanced performance even in older animals. Human research shows exercise dramatically increases MOTS-c levels, and it correlates with better endurance and metabolic health.
Tesamorelin: Proven Visceral Fat Reducer
In two large Phase 3 trials with HIV patients who had excess belly fat, 2 mg daily Tesamorelin reduced visceral adipose tissue by about 15% over 26 weeks, while increasing lean body mass and improving lipid profiles. It is FDA-approved for this specific use and works by gently raising natural growth hormone pulses.
Why This Blend? Complementary Fat-Loss and Recomposition Effects
- AOD-9604 helps break down and release stored fat.
- MOTS-c improves how cells burn that fat for energy and supports endurance during training.
- Tesamorelin specifically shrinks dangerous visceral fat and supports lean mass.
For active people, the blend aims to “shred fat while building performance” — reducing body fat percentage, preserving muscle, and improving workout recovery and energy. Many users stack it with a GLP medication for stronger appetite suppression, creating a powerful four-way approach to fat loss and body recomposition. The mechanisms (lipolysis + metabolic signaling + GH-driven visceral fat targeting) align well for synergistic results.
Important Caveats from the Science
Tesamorelin has the strongest human evidence (FDA-approved for visceral fat in specific patients). AOD-9604 and MOTS-c have supportive preclinical and smaller human data. This specific 1.2/2/3 mg/mL blend is a compounded research product — not FDA-approved or tested as a combination. Long-term safety, ideal dosing, and consistent quality can vary between compounding pharmacies. Potential side effects include injection-site reactions, mild water retention (from Tesamorelin), or temporary fatigue. Rapid fat loss requires medical supervision, adequate protein intake, and resistance training to protect muscle. These are research compounds. Always consult a doctor and get regular bloodwork.
The Bottom Line
The AOD-9604 / MOTS-c / Tesamorelin compounded blend combines direct fat mobilization, mitochondrial/metabolic enhancement, and proven visceral fat reduction into one injectable “Fat Burner Blend.” It is popular among active individuals who want to shred fat while maintaining performance and muscle. When paired with a GLP for appetite control, it becomes an aggressive recomposition tool. Promising science backs the individual components, but rigorous human trials on this exact blend are still needed. As with any advanced peptide protocol, it works best as part of a complete program including training, nutrition, and professional medical oversight.
This information is not medical advice. Results vary by individual, and these compounds should be used only under the supervision of a qualified healthcare provider with appropriate monitoring (including regular bloodwork). They are not substitutes for a healthy diet, exercise, sleep, or standard medical care. Always consult your doctor before starting any peptide or compounded regimen.
